Regulatory Requirements and Innovation: A Comparison of the Dermatologic Antifungal Drug Product Markets in Brazil and United States.

Bianca KollrossMarcilio Cunha-FilhoGuilherme Martins GelfusoTais Gratieri

Published in: Therapeutic innovation & regulatory science (2018)

Despite the great number of registered products, the Brazilian market lacks the latest technologies, reflecting that the ease of generics registration is not accompanied by innovation.

Keyphrases

candida albicans
transcription factor
health insurance
adverse drug
drug induced